Package 65862-026-30

{"route": ["ORAL"], "spl_id": "0c6a0ca4-d63c-4018-909a-d9e7a2821ed4", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["a8a492ab-396a-4b7c-99b3-bcb6d3386f71"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (65862-026-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "65862-026-10", "marketing_start_date": "20161121"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-026-30)", "package_ndc": "65862-026-30", "marketing_start_date": "20161121"}], "brand_name": "Lamivudine", "product_id": "65862-026_0c6a0ca4-d63c-4018-909a-d9e7a2821ed4", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-026", "generic_name": "Lamivudine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA077464", "marketing_category": "ANDA", "marketing_start_date": "20161121", "listing_expiration_date": "20261231"}